Understanding the Care for Headache in Emergency Departments: Anne-Maree Kelly, MD
December 14th 2021The director of the Joseph Epstein Center for Emergency Medicine Research discussed the origin behind her multinational study evaluating the outcome of headache in emergency departments. [WATCH TIME: 3 minutes]
Ganaxolone’s Potential in TSC, Need for More Drug Development: Darcy Krueger, MD, PhD
December 12th 2021The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the phase 2 open-label study of ganaxolone in TSC and whether drug development remains the top priority for these patients. [WATCH TIME: 3 minutes]
Recent Advances, Future Developments in Epilepsy Surgery: Imad Najm, MD
December 10th 2021The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute spoke on the latest advances with epilepsy surgery, as well as what still needs to be learned. [WATCH TIME: 5 minutes]
Behavioral Treatment Strategies for Migraine Management
An expert panel discusses migraine prevention with the use of behavioral therapies such as cognitive behavioral therapy and stress management.
Cenobamate’s Efficacy Profile in Treating Seizures: William Rosenfeld, MD
December 9th 2021The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed numerous presentations from AES 2021 that bolstered cenobamate’s known efficacy and safety profile. [WATCH TIME: 7 minutes]
Vaccination and Seizure Risk in Dravet Syndrome: Veronica Hood, PhD, MS
December 8th 2021The scientific director at the Dravet Syndrome Foundation commented on the concern associated with vaccination in this patient population, noting that investigators have not observed an exacerbated risk profile with the COVID-19 vaccines. [WATCH TIME: 2 minutes]
Exploring the Benefits of CBT for Psychogenic Non-Epileptic Seizures: Becky Tilahun, PhD
December 5th 2021The clinical psychologist at Cleveland Clinic discussed the potential of using cognitive behavioral therapy for treatment of psychogenic non-epileptic seizures on cognitive behavioral therapy. [WATCH TIME: 3 minutes]
Encouraging Signs in Alzheimer Drug Development Despite Failures: Jeffrey Cummings, MD, ScD
December 3rd 2021The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas discussed the positive trends within the Alzheimer drug development space. [WATCH TIME: 2 minutes]
Discussing Preventative Migraine Lifestyle Changes with Patients
Dr Andrew Charles shares how he eases patient anxieties over lifestyle changes for preventive migraine therapy.
Non-Drug Therapies for Migraine Prevention: Lifestyle Changes
Rebecca Erwin Wells, MD, MPH, details the effectiveness of lifestyle changes for preventative migraine treatment.
The Substantial Costs Affiliated With Alzheimer Drug Development: Jeffrey Cummings, MD, ScD
December 2nd 2021The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas discussed new data that highlights wasted expenditures from Alzheimer trials and the importance of understanding their impacts. [WATCH TIME: 3 minutes]
Future Integration, Coverage for Telemedicine in Multiple Sclerosis: Marisa McGinley, DO
December 1st 2021The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed the necessary data to support telemedicine’s integration into clinical care. [WATCH TIME: 4 minutes]